Shawver Laura
CIK 0001551891
Chief Executive OfficerDirector
Filings
22
Latest Jun 27, 2025
Issuers covered
3
Showing
22 of 22
Page 1
Track record
9 of 23 open-market trades scored (39% price coverage) - 14 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 9 | 56% | +4.2% | +11.7% | +22.4% | -18.9% |
| 90 days | 9 | 44% | -3.0% | -15.8% | +27.1% | -33.7% |
| 180 days | 9 | 11% | -11.6% | -6.2% | +20.0% | -54.2% |
| 365 days | 9 | 89% | +23.4% | +29.8% | +36.5% | -0.6% |
Issuers
Companies where Shawver Laura has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| SPRY | Ars Pharmaceuticals, Inc. | 17 | Jun 27, 2025 |
| RLAY | Relay Therapeutics, Inc. | 4 | Jun 5, 2024 |
| NKTX | Nkarta, Inc. | 1 | Jun 10, 2022 |
All filings
22 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|